Wilson Sonsini Goodrich & Rosati has advised Circle Pharma. Circle Pharma, Inc., a clinical-stage biopharmaceutical company specializing in targeted macrocycle therapeutics for cancer, has announced the...
Circle Pharma Secures $92.5 Million in Series E Financing
Circle Pharma’s Research Collaboration with Boehringer Ingelheim
Wilson Sonsini advised Circle Pharma on the transaction. Circle Pharma (Circle), a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class...
Circle Pharma’s $90 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...